MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s11033-024-09291-1

Медицинская библиотека · Molecular biology reports · 2024

Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.

Rasmi Yousef, di Bari Ighli, Faisal Shah, Haque Munima, Aramwit Pornanong, da Silva Aline, Roshani Asl Elmira

СтатьяОбзорПеревод пока не подготовлен

Аннотация

Human SARS Coronavirus-2 (SARS-CoV-2) has infected more than 170 million people worldwide, being responsible for about 3.5 million deaths so far. Despite ongoing investigations, there is still more to understand the mechanism of COVID-19 infection completely. However, it has been evidenced that SARS-CoV-2 can cause Coronavirus disease (COVID-19) notably in diabetic people. Approximately 35% of the patients who died of this disease had diabetes. A growing number of studies have evidenced that hyperglycemia is a significant risk factor for severe SARS-CoV-2 infection and plays a key role in COVID-19 mortality and diabetes comorbidity. The uncontrolled hyperglycemia can produce low-grade inflammation and impaired immunity-mediated cytokine storm that fail multiple organs and sudden death in diabetic patients with SARS-CoV-2 infection. More importantly, SARS-CoV-2 infection and interaction with ACE2 receptors also contribute to pancreatic and metabolic impairment. Thus, using of diabetes medications has been suggested to be beneficial in the better management of diabetic COVID-19 patients. Herbal treatments, as safe and affordable therapeutic agents, have recently attracted a lot of attention in this field. Accordingly, in this review, we intend to have a deep look into the molecular mechanisms of diabetic complications in SARS-CoV-2 infection and explore the therapeutic potentials of herbal medications and natural products in the management of diabetic COVID-19 patients based on recent studies and the existing clinical evidence.

Для цитирования: Rasmi Yousef, di Bari Ighli, Faisal Shah, Haque Munima, Aramwit Pornanong, da Silva Aline, Roshani Asl Elmira. Herbal-based therapeutics for diabetic patients with SARS-Cov-2 infection.. Molecular biology reports. 2024. DOI: 10.1007/s11033-024-09291-1.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.